Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids
- PMID: 8627734
- PMCID: PMC190037
- DOI: 10.1128/JVI.70.3.2044-2048.1996
Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids
Abstract
We have constructed defined human cytomegalovirus (CMV) mutants by cotransfecting overlapping cosmid clones spanning the 230-kbp genome. Using this strategy, we have introduced a 13-kbp region of DNA from a virulent strain of CMV into a defined position within the avirulent CMV(Towne) genome. Although more than 80% of the genome of these recombinant viruses was derived from Towne DNA, their plaque morphology more closely resembled that of Toledo. To date, CMV is the largest virus and requires the greatest number of cosmids to be regenerated via overlapping cosmid cotransfection.
Similar articles
-
Cleavage maps of human cytomegalovirus genome (strain Towne) determined by the use of cosmid cloning system.Arch Virol. 1986;88(3-4):241-50. doi: 10.1007/BF01310878. Arch Virol. 1986. PMID: 3010906
-
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.J Virol. 1996 Jan;70(1):78-83. doi: 10.1128/JVI.70.1.78-83.1996. J Virol. 1996. PMID: 8523595 Free PMC article.
-
Epstein-Barr virus recombinants from overlapping cosmid fragments.J Virol. 1993 Dec;67(12):7298-306. doi: 10.1128/JVI.67.12.7298-7306.1993. J Virol. 1993. PMID: 8230453 Free PMC article.
-
Recombinant cytomegaloviruses for study of replication and pathogenesis.Intervirology. 1996;39(5-6):320-30. doi: 10.1159/000150503. Intervirology. 1996. PMID: 9130042 Review.
-
Mutagenesis of the cytomegalovirus genome.Curr Top Microbiol Immunol. 2008;325:41-61. doi: 10.1007/978-3-540-77349-8_3. Curr Top Microbiol Immunol. 2008. PMID: 18637499 Review.
Cited by
-
A genetic system for rhesus monkey rhadinovirus: use of recombinant virus to quantitate antibody-mediated neutralization.J Virol. 2006 Feb;80(3):1549-62. doi: 10.1128/JVI.80.3.1549-1562.2006. J Virol. 2006. PMID: 16415030 Free PMC article.
-
Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus.Vaccine. 2007 Oct 16;25(42):7441-9. doi: 10.1016/j.vaccine.2007.08.016. Epub 2007 Aug 30. Vaccine. 2007. PMID: 17870214 Free PMC article.
-
Resistance of human cytomegalovirus to antiviral drugs.Clin Microbiol Rev. 1999 Apr;12(2):286-97. doi: 10.1128/CMR.12.2.286. Clin Microbiol Rev. 1999. PMID: 10194460 Free PMC article. Review.
-
Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.Hum Vaccin Immunother. 2018 Feb 1;14(2):292-303. doi: 10.1080/21645515.2017.1391433. Epub 2017 Dec 1. Hum Vaccin Immunother. 2018. PMID: 29053403 Free PMC article.
-
Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection.J Virol. 2000 Oct;74(19):9333-7. doi: 10.1128/jvi.74.19.9333-9337.2000. J Virol. 2000. PMID: 10982383 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources